Keywords: eisai, china, enters, repackaging, sales, deal, stada

Eisai China enters repackaging and sales deal for Stada's Alpha-Lipon 300

Article | 11 August 2008

Print This

The Chinese unit of Japanese drugmaker Eisai has entered into license agreement with Health Vision Enterprise, a sales subsidiary of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in